Literature DB >> 2642584

von Hippel-Lindau disease affecting 43 members of a single kindred.

J M Lamiell1, F G Salazar, Y E Hsia.   

Abstract

We present a 6-generation kindred of over 221 members, 43 of whom were affected with von Hippel-Lindau (vHL) disease. Through a simple screening protocol, we diagnosed vHL retrospectively in 15 cases, and for the first time in 28, 11 of whom were presymptomatic. We found many complications of vHL in previously diagnosed relatives and in new cases. This study has demonstrated the utility and benefit of preventive surveillance in those known to have vHL, and of presymptomatic screening for affected relatives in families with vHL. The features of vHL were reviewed in our 43 cases and 511 cases from the medical literature. The patterns, frequencies, and ages of onset for each lesion were compared. Renal malignancies caused almost as much mortality in vHL as CNS malignancies. This family was exceptional for absence of pheochromocytoma and erythrocythemia, for more renal and pancreatic cysts and malignancies, and for slightly fewer eye or CNS lesions. Bilateral renal adenocarcinomata were found presymptomatically in five young subjects, who had bilateral nephrectomy and hemodialysis. Three survived long-term after renal transplants. Five relatives had pancreatic malignancies, which are definite although uncommon manifestations of vHL. Recommendations are made for family screening, which was economical and effective. Bayesian calculations help to predict risks for genetic counseling. The molecular basis of vHL may soon be found, since it has been linked to DNA markers on the short arm of chromosome 3.

Entities:  

Mesh:

Year:  1989        PMID: 2642584     DOI: 10.1097/00005792-198901000-00001

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  62 in total

1.  Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.

Authors:  A O Vortmeyer; I A Lubensky; F Fogt; W M Linehan; U Khettry; Z Zhuang
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer.

Authors:  Haris Zahoor; Maria C Mir; Pedro C Barata; Andrew J Stephenson; Steven C Campbell; Amr Fergany; Robert Dreicer; Jorge A Garcia
Journal:  Invest New Drugs       Date:  2019-06-24       Impact factor: 3.850

Review 3.  [Capillary hemangioma of the retina in cases of von Hippel-Lindau syndrome. New therapeutic directions].

Authors:  N Bornfeld; K-M Kreusel
Journal:  Ophthalmologe       Date:  2007-02       Impact factor: 1.059

4.  Neurologic manifestations of von Hippel-Lindau disease.

Authors:  John A Butman; W Marston Linehan; Russell R Lonser
Journal:  JAMA       Date:  2008-09-17       Impact factor: 56.272

5.  A von Hippel-Lindau disease-associated microcystic adenoma of the ethmoid sinus: case report.

Authors:  David S Xu; Michael S Dirks; Martha M Quezado; Irina A Lubensky; Zhengping Zhuang; Russell R Lonser; Ashok R Asthagiri
Journal:  Neurosurgery       Date:  2011-10       Impact factor: 4.654

6.  Genetics of Von Hippel-Lindau Disease.

Authors:  D C Dwyer; R K Tu
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-17       Impact factor: 3.825

7.  Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.

Authors:  E R Maher; J R Yates; M A Ferguson-Smith
Journal:  J Med Genet       Date:  1990-05       Impact factor: 6.318

8.  Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect.

Authors:  H Brauch; T Kishida; D Glavac; F Chen; F Pausch; H Höfler; F Latif; M I Lerman; B Zbar; H P Neumann
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

9.  Longitudinal analysis of retinal hemangioblastomatosis and visual function in ocular von Hippel-Lindau disease.

Authors:  Brian C Toy; Elvira Agrón; Divya Nigam; Emily Y Chew; Wai T Wong
Journal:  Ophthalmology       Date:  2012-08-17       Impact factor: 12.079

10.  Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease.

Authors:  Russell R Lonser; John A Butman; Kristin Huntoon; Ashok R Asthagiri; Tianxia Wu; Kamran D Bakhtian; Emily Y Chew; Zhengping Zhuang; W Marston Linehan; Edward H Oldfield
Journal:  J Neurosurg       Date:  2014-02-28       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.